Senomyx, Inc.
http://www.senomyx.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Senomyx, Inc.
Microscience IPO: With a Little Help From Its Friends
Unusually, the VC investors in UK-based Microscience have announced they will pump a further £10 million into the vaccine developer as it tries to enter the lukewarm public markets with a summer IPO on London's AIM. With underwhelming debuts from Ark Therapeutics and Basilea Pharmaceutica in Europe and dramatically reduced offering prices in both Europe and the US, Microscience's investors' show of solidarity may make a necessary difference. But in the end, it's still all about the valuation.
Ambryx Inc.
Ambryx (now Senomyx Inc.) will develop products for the food and fragrance markets, based on the receptor biology of chemosensation. Specifically, the new company will develop molecules that manufacturers can put into products to affect a consumer's perception of taste and smell.
Company Information
- Industry
- Distributors
- Miscellaneous
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice